LBIO (Longevity Biomedical) Market Cap: $0.00 Mil (As of Jul. 02, 2026)


What is Longevity Biomedical Market Cap?

Longevity Biomedical LBIO Market Cap is $0.00 Mil as of Jul. 02, 2026.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Longevity Biomedical's share price for the quarter that ended in . 20 was $. Longevity Biomedical's Shares Outstanding (EOP) for the quarter that ended in . 20 was 0.00 Mil. Therefore, Longevity Biomedical's market cap for the quarter that ended in . 20 was $ Mil.

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Longevity Biomedical's Enterprise Value for Today is $0.00 Mil.

Longevity Biomedical  (NAS:LBIO) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Longevity Biomedical Market Cap Related Terms

Longevity Biomedical Market Cap Historical Data

* Premium members only.

The historical data trend for Longevity Biomedical's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Longevity Biomedical Market Cap Chart

Longevity Biomedical Annual Data
Trend
Market Cap

Longevity Biomedical Semi-Annual Data
Market Cap

LBIO vs : Market Cap Comparison

For the Biotechnology subindustry, Longevity Biomedical's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Longevity Biomedical Market Cap vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Longevity Biomedical's Market Cap distribution charts can be found below:

* The bar in red indicates where Longevity Biomedical's Market Cap falls into.


Longevity Biomedical Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Longevity Biomedical's Market Cap for the fiscal year that ended in . 20 is calculated as

Market Cap (A: . 20 )=Share Price (A: . 20 )*Shares Outstanding (EOP) (A: . 20 )
=$*
=$

Longevity Biomedical's Market Cap for the quarter that ended in . 20 is calculated as

Market Cap (Q: . 20 )=Share Price (Q: . 20 )*Shares Outstanding (EOP) (Q: . 20 )
=$*0
=$

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of $0.00 Mil mean?
Longevity Biomedical (LBIO) has a Market Cap of $0.00 Mil as of Jul. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Longevity Biomedical and its competitors.
Is Longevity Biomedical's Market Cap too high?
Longevity Biomedical's current Market Cap is $0.00 Mil.
How does Longevity Biomedical's Market Cap compare to ?
Longevity Biomedical's Market Cap of $0.00 Mil can be compared against companies in the Biotechnology industry. The industry median Market Cap is 119.04. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 119.04, based on 1,427 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Longevity Biomedical and its competitors. For the Biotechnology industry, the median Market Cap is 119.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Longevity Biomedical's current Market Cap is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Longevity Biomedical stock overvalued right now?
Longevity Biomedical (LBIO) has a current Market Cap of $0.00 Mil. The current Market Cap is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Longevity Biomedical (LBIO), the current Market Cap is $0.00 Mil as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Longevity Biomedical Business Description

Comparable Companies
Address 12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011
Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.